Most Recent

image: Science March Sights and Signs

Science March Sights and Signs

By , , , and | April 22, 2017

Thousands of people around the world gathered to show support for science today. Here’s a sampling of sights and signs from the Marches for Science in Berlin, Chicago, and Washington, DC.

0 Comments

image: Marching Into an Uncertain Future

Marching Into an Uncertain Future

By | April 20, 2017

Can professional organizations and societies parlay the groundswell of support culminating in this weekend’s March for Science into more-effective science advocacy?

1 Comment

image: TS Picks: April 20, 2017

TS Picks: April 20, 2017

By | April 20, 2017

March for Science edition

0 Comments

image: Sociologists to Study the March for Science

Sociologists to Study the March for Science

By | April 17, 2017

Researchers hope to use the upcoming event as an opportunity to examine the social science of political activism among science supporters.

0 Comments

image: New Giant Virus Group Reported

New Giant Virus Group Reported

By | April 6, 2017

A genomic analysis of “Klosneuviruses” suggests that they evolved from small viruses that accumulated genetic material over time, but not all virologists are convinced. 

0 Comments

image: Contributors

Contributors

By | April 1, 2017

Meet some of the people featured in the April 2017 issue of The Scientist.

0 Comments

image: Hitting It Out of the Park

Hitting It Out of the Park

By | April 1, 2017

Cancer can be as evasive and slippery as a spitball, but new immunotherapies are starting to connect.

0 Comments

image: Location, Location, Location

Location, Location, Location

By | April 1, 2017

Since first proposing that a cell’s function and biology depend on its surroundings, Mina Bissell continues to probe the role of the extracellular matrix.

2 Comments

image: Making CAR T-Cell Therapy Safer

Making CAR T-Cell Therapy Safer

By | April 1, 2017

Following a spate of patient deaths in clinical trials testing modified T cells for the treatment of cancer, researchers work to reduce the treatment’s toxicity without sacrificing efficacy.

0 Comments

Measuring PD-L1 levels was a great start. Now we need to quantify more protein biomarkers, assess the tumor mutational landscape, and examine immune cell signatures, too.

0 Comments

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Human Cord Plasma Protein Boosts Cognitive Function in Older Mice
AAAS